Prot# 2007008: A Non-Inferiority Comparison of 35mg Delayed-Release Risedronate, Administered Once-Weekly Either Before or After Breakfast, and 5mg Immediate-Release Risedronate, Administered Once-Daily Before Breakfast, in the Treatment of Postmenopausal

Project: Research project

Project Details

StatusFinished
Effective start/end date1/3/08 → 1/3/11

Funding

  • Parexel (2007008 // 2007008)
  • Procter & Gamble Company (2007008 // 2007008)